Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
EarlyDiagnostics logo — A leader in non-invasive genomics, early cancer diagnostics,...

EarlyDiagnostics

A leader in non-invasive genomics, early cancer diagnostics, biomarker & CDx

Founded 2017 United States Los Angeles, United States 8 employees Unknown Biotechnology, Health Care

General Information

Company Name EarlyDiagnostics
Founded Year 2017
Location United States Los Angeles, United States +1
Employees 8
Industries Biotechnology, Health Care
Funding Stage Unknown
Social

Get notified when EarlyDiagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EarlyDiagnostics

EarlyDiagnostics, established in 2017 and headquartered in the United States, is a promising player in the Biotechnology and Health Care sectors. The company positions itself as "A leader in non-invasive genomics, early cancer diagnostics, biomarker & CDx."

With a focus on cfDNA-based technologies, EarlyDiagnostics has developed a suite of innovative tools like cfMethyl-seq, cfSNV, and cfTrack, which are designed to enhance diagnostics accuracy and monitoring capabilities for various diseases, including cancer. These tools are powered by sophisticated AI algorithms, ensuring high precision in biomarker discovery and diagnostics.

Despite its apparent technological prowess, the company has yet to announce its latest round of financing, and key investors remain unnamed. Potential investors might find this an opportune moment to engage, given the company's robust foundation in precision medicine and expanding market potential.

Taxonomy: Non-Invasive Genomics, Early Cancer Diagnostics, Biomarker Discovery, Precision Medicine, cfDNA Technologies, cfMethyl-seq, cfSNV, Cancer Monitoring, MRD Detection, AI Algorithms in Genomics, Liquid Biopsy, Bioinformatics Platform, Metabolic Disease Diagnostics, Neurological Disease Diagnostics, Autoimmune Disease Diagnostics

Services & Products

Early cancer detection
Liquid biopsy assays
Bioinformatics solutions
Cancer therapy selection
Cancer treatment monitoring

Target Customers

Diagnostic companies Healthcare providers Biopharmaceutical companies Cancer patients Medical researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Unknown •••••• - 01 Jan 2019

EarlyDiagnostics Alternatives & Competitors

EarlyDiagnostics vs
CrossLife Technologies Inc.
CrossLife Technologies Inc. United States

Technologies for Better Life CrossLife Technologies is a life sciences company founded with t...

Grant
6 employees
Biotechnology, Health Care
EarlyDiagnostics vs
DeepSound AI
DeepSound AI United States

Reveal all the secrets that sound keeps with cutting-edge DeepSound AI technology.

Pre Seed
3 employees
AI, Machine Learning
EarlyDiagnostics vs
Anchor Molecular
Anchor Molecular United States

Best-in-Class Quality Controls and Reference Materials for Molecular Testing

2 employees
Biotechnology, Health Care

FAQ About EarlyDiagnostics

A leader in non-invasive genomics, early cancer diagnostics, biomarker & CDx
EarlyDiagnostics was founded in 2017.
EarlyDiagnostics is headquartered in Los Angeles, United States.
EarlyDiagnostics operates in the following industries: Biotechnology, Health Care.
EarlyDiagnostics has approximately 8 employees.
EarlyDiagnostics has completed 1 funding round. The latest funding stage is Unknown.
EarlyDiagnostics offers: Early cancer detection, Liquid biopsy assays, Bioinformatics solutions, Cancer therapy selection, Cancer treatment monitoring.
Top alternatives and competitors to EarlyDiagnostics include CrossLife Technologies Inc., DeepSound AI, Anchor Molecular, Arquer Diagnostics, Molbio Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EarlyDiagnostics and CrossLife Technologies Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EarlyDiagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy